N
VCNX

Natixis’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Natixis’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-152
Closed -$33K – 1360
2021
Q4 		$33K Hold
152
– – ﹤0.01% 1202
2021
Q3 		$69K Buy
+152
New +$75.8K ﹤0.01% 1169
2021
Q2 		– Sell
-85
Closed -$53K – 1158
2021
Q1 		$53K Buy
+85
New +$54.6K ﹤0.01% 1049

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Natixis's VCNX Position: Q1 2022 in Review

Natixis sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2022, closing a stake of 152 shares — an estimated $33K sold.

Natixis first reported a position in VCNX in Q1 2021 and held it in 3 quarters. The position peaked at $69K in Q3 2021. 25 funds tracked by Wall St. Rank hold VCNX as of Q1 2022.

  • Natixis reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Natixis sold 152 Vaccinex, Inc. Common Stock shares in Q1 2022, an estimated $33K.
  • Natixis first reported a position in Vaccinex, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Natixis's Vaccinex, Inc. Common Stock position peaked at $69K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2022.

Based on Natixis's 13F filing for Q1 2022, filed 13 May 2022.